Brite Therapeutics
PrivateCompany Overview
Brite Therapeutics is a biotechnology company that develops novel treatments for obesity and related metabolic disorders by targeting brown and brite fat cell biology and advancing drug combinations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
obesity treatmentmetabolic disordersdrug discoveryGLP-1 therapycombination therapyfat cell biologyweight loss drugtarget validationhigh-throughput screeningbioinformaticsdrug repurposingbiotech partnershipclinical-stage biotechmetabolic researchobesity pipeline
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brite Therapeutics Comparables
Compare Brite Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Energesis Pharmaceuticals, Inc. | 85% | |
| Eolo Pharma | 83% | |
| Adipo Therapeutics | 79% | |
Brite Therapeutics Funding Rounds
Historical fundraising activity
Brite Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brite Therapeutics's valuation, stock price, and market status.
See something wrong or outdated?